17-beta-estradiol
Advanced Triple-Negative Breast Carcinoma
Mayo ClinicPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Advanced Triple-Negative Breast Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Bms-907351 National Cancer Institute (NCI) | Phase 1 | CC |
Fermented Wheat Germ Extract University of California, Davis | Phase 1 | CC |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →